Juvederm Vollure Lip Filler
Juvéderm Vollure XC can be injected into lips, but this use remains off-label in the United States. FDA approval covers moderate to severe facial folds, not lip augmentation. Vollure contains 17.5 mg/mL crosslinked hyaluronic acid and 0.3% lidocaine.
- Last updated
- 46 reads
- 4 min read
Juvéderm Vollure XC can be injected into lips, but this use remains off-label in the United States. FDA approval covers moderate to severe facial folds, not lip augmentation. Vollure contains 17.5 mg/mL crosslinked hyaluronic acid and 0.3% lidocaine. Controlled lip studies instead support Juvéderm Volbella XC and Ultra XC. Therefore, Vollure’s advertised 18-month duration cannot be directly applied to lips. Safe treatment requires informed consent, anatomical expertise, and immediate vascular-occlusion management. Product choice should follow lip anatomy, desired projection, tissue support, and the injector’s documented experience.
Is Juvederm Vollure FDA-Approved for Lip Filler?
No, Juvéderm Vollure XC is not FDA-approved specifically for lip augmentation in the United States.
Its approved indication covers mid-to-deep dermal injection for moderate or severe facial wrinkles and folds. The label names nasolabial folds as an example. Using Vollure in lips therefore falls outside its approved anatomical indication. That distinction does not automatically make treatment improper or unsafe. However, controlled FDA-reviewed Vollure data concern facial folds, not lip outcomes. Juvéderm Volbella XC and Ultra XC carry specific American lip-augmentation indications. Patients should ask whether the proposed product is approved for that exact treatment area.
What Is Juvederm Vollure and How Does It Change the Lips?
Juvéderm Vollure XC is a biodegradable hyaluronic acid gel that adds temporary volume within injected tissue.
It contains 17.5 mg/mL crosslinked hyaluronic acid and 0.3% lidocaine. The hyaluronic acid attracts and retains water while physically supporting nearby tissue. Lidocaine reduces injection discomfort but does not eliminate pressure or tenderness. In lips, an injector may use the gel to change contour, projection, or symmetry. Those lip effects remain off-label under current United States labeling. Vollure does not stimulate permanent lip growth or stop natural aging. The body gradually degrades the implanted gel through normal biological processes.
How Does Vollure Compare With Volbella for Lip Augmentation?
Volbella has FDA-reviewed lip data, while Vollure has FDA-reviewed evidence for facial folds.
Volbella contains 15 mg/mL hyaluronic acid, compared with Vollure’s 17.5 mg/mL concentration. Both products include 0.3% lidocaine. Concentration alone cannot predict softness, lift, swelling, or final appearance. Gel structure, injection depth, volume, and tissue anatomy also influence behavior. Volbella’s lip study included 168 treated participants and followed outcomes through one year. Vollure’s pivotal study treated nasolabial folds in 123 participants. Therefore, stronger lip-specific evidence supports Volbella, while Vollure requires off-label consent.
How Long Does Juvederm Vollure Last in the Lips?
No controlled FDA-reviewed study establishes how long Juvéderm Vollure lasts specifically in the lips.
The often-repeated 18-month claim comes from its nasolabial-fold study. At 18 months, 59.4% of evaluated folds still met the study’s responder definition. That result cannot be transferred directly to lip tissue. Lips move frequently and have different anatomy, vascularity, and mechanical stress. Injected volume and technique also change apparent longevity. Some patients may notice shorter or longer persistence, but exact prediction remains impossible. Ask providers to separate approved fold-duration data from their own lip experience.
What Side Effects Can Vollure Lip Filler Cause?
Vollure lip filler can cause temporary swelling, tenderness, bruising, firmness, redness, pain, itching, and lumps.
However, Vollure’s published trial frequencies come from nasolabial folds. They should not be presented as exact lip-specific percentages. Early swelling can temporarily exaggerate volume or asymmetry. Delayed nodules, infection, migration, inflammatory reactions, or herpes reactivation may also occur. Rare intravascular injection can cause skin necrosis, visual impairment, blindness, or stroke. A trained injector must understand lip vessels and emergency treatment. Patients should delay judging symmetry until expected swelling has substantially settled.
Who Should Avoid or Postpone Vollure Lip Filler?
People with specific allergies, active infections, or unresolved medical risks should avoid or postpone Vollure treatment.
-
Severe anaphylaxis history or multiple severe allergies makes Vollure contraindicated.
-
Lidocaine allergy makes the XC formulation contraindicated.
-
Allergy to Gram-positive bacterial proteins also prevents treatment.
-
Active pimples, rashes, hives, herpes, or infection require postponement.
-
Pregnancy and breastfeeding safety has not been established.
-
Immunosuppressive treatment requires additional caution and medical review.
Discuss anticoagulants, bleeding risks, recent procedures, and previous fillers before injection. Never stop prescribed medication solely to qualify for cosmetic treatment.
What Are the Warning Signs of Vascular Occlusion?
Seek urgent medical assessment when unusual pain, blanching, vision changes, or neurological symptoms appear after filler.
-
Sudden skin whitening may indicate reduced blood supply.
-
Increasing pain can signal vascular compromise rather than routine tenderness.
-
Blurred vision, vision loss, or eye pain requires immediate emergency care.
-
Weakness, speech difficulty, confusion, or severe headache may indicate stroke.
-
Dusky discoloration, cool skin, or blistering can precede tissue damage.
The injector should stop treatment immediately when vascular occlusion becomes suspected. Prompt specialist assessment may protect skin, eyesight, and neurological function. Routine swelling alone differs from these rapidly developing warning signs.
References
-
FDA, JUVÉDERM VOLLURE XC Premarket Approval Record
https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P110033S020 -
FDA, JUVÉDERM VOLLURE XC Summary of Safety and Effectiveness Data
https://www.accessdata.fda.gov/cdrh_docs/pdf11/P110033S020B.pdf -
AbbVie, JUVÉDERM VOLLURE XC Directions for Use
https://www.rxabbvie.com/pdf/juvederm-vollure-xc_dfu.pdf -
AbbVie, JUVÉDERM VOLLURE XC Patient Labeling
https://www.rxabbvie.com/pdf/juvederm-vollure-xc_pt_lb.pdf -
AbbVie, JUVÉDERM VOLBELLA XC Directions for Use
https://www.rxabbvie.com/pdf/juvederm-volbella_dfu.pdf -
AbbVie, JUVÉDERM VOLBELLA XC Lip Augmentation Patient Labeling
https://www.rxabbvie.com/pdf/juvederm-volbella_lp_aug_pr_ln_pt_lb.pdf
- Last updated
- Language
- English
How did you find this article?
Nasolabial fold filler is a nonsurgical facial rejuvenation treatment used to soften the lines that run from the sides of the nose toward the corners of the mouth. This guide walks you through how to prepare, choose the right provider, understand the treatment process, care for your results.
A liquid rhinoplasty can be an appealing option for people who want subtle nose contouring without surgery, but it is still a medical procedure with real risks. The most serious concern is vascular compromise, where filler affects blood flow and can lead to skin injury, necrosis, vision-related complication.
Lip fillers are injectable dermal fillers used to add volume, define the lip border, smooth fine lines around the mouth, or create better balance between the upper and lower lip. In the United States, the best-known lip filler brands are usually hyaluronic acid fillers.
Subscribe to the Medifinder newsletter and never miss our latest content.